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Berkshire, United Kingdom
Abstract
Activating transcription factor 3 (Atf3) is rapidly and transiently upregulated in numerous systems, and is associated with
various disease states. Atf3 is required for negative feedback regulation of other genes, but is itself subject to negative
feedback regulation possibly by autorepression. In cardiomyocytes, Atf3 and Egr1 mRNAs are upregulated via ERK1/2
signalling and Atf3 suppresses Egr1 expression. We previously developed a mathematical model for the Atf3-Egr1 system.
Here, we adjusted and extended the model to explore mechanisms of Atf3 feedback regulation. Introduction of an
autorepressive loop for Atf3 tuned down its expression and inhibition of Egr1 was lost, demonstrating that negative
feedback regulation of Atf3 by Atf3 itself is implausible in this context. Experimentally, signals downstream from ERK1/2
suppress Atf3 expression. Mathematical modelling indicated that this cannot occur by phosphorylation of pre-existing
inhibitory transcriptional regulators because the time delay is too short. De novo synthesis of an inhibitory transcription
factor (ITF) with a high affinity for the Atf3 promoter could suppress Atf3 expression, but (as with the Atf3 autorepression
loop) inhibition of Egr1 was lost. Developing the model to include newly-synthesised miRNAs very efficiently terminated
Atf3 protein expression and, with a 4-fold increase in the rate of degradation of mRNA from the mRNA/miRNA complex,
profiles for Atf3 mRNA, Atf3 protein and Egr1 mRNA approximated to the experimental data. Combining the ITF model with
that of the miRNA did not improve the profiles suggesting that miRNAs are likely to play a dominant role in switching off
Atf3 expression post-induction.
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Introduction
The concept of immediate early genes (IEGs) was initially
established in relation to viral infection of bacterial or eukaryotic
cells (e.g. herpesvirus [1]). Here, IEGs are defined as the genes
encoding the first phase of mRNAs expressed from the viral
genome, relying entirely on pre-existing host proteins. Early and
delayed genes are expressed later and require production of new
proteins. In mammalian cells, IEGs became defined as those
which are regulated by pre-existing transcription factors (TFs) such
that increases in IEG mRNA expression are not suppressed by
protein synthesis inhibitors (e.g. cycloheximide) [2]. Many IEGs
encode transcriptional regulators that are required to modulate
downstream gene expression (i.e. second phase genes) and some
are inhibitory factors required to terminate transcription. With the
discovery of miRNAs that influence mRNA expression and
translation [3,4], some adjustment of the IEG concept is necessary
according to whether mRNA regulation is transcriptional or post-
transcriptional. Synthesis, production and degradation of miRNAs
may be insensitive to inhibitors of protein synthesis as would be
any (post-transcriptional) effects on mRNA expression.
Cardiomyocytes, the contractile cells of the heart, withdraw
from the cell cycle perinatally. Neonatal rat cardiomyocytes are
therefore highly synchronized and, because they do not divide,
form a good model for the study of IEG regulation. In these cells,
endothelin-1 (ET-1), a Gq protein-coupled receptor (GqPCR)
agonist, elicits maximal activation of the entire pool of extracel-
lular signal-regulated kinases 1/2 (ERK1/2, the prototypic
mitogen-activated protein kinases) within 3–5 min [5,6]. The
earliest IEGs are substantially and maximally upregulated within
15–30 min, with second phase RNAs being detected within 1 h
[7]. ERK1/2 play a major role in the response and promote
upregulation of ,70% of ET-1-responsive transcripts [7,8].
Recent data indicate that ERK1/2 act together with their
downstream substrates p90 ribosomal S6 kinases (RSKs) to
regulate RNA expression, with RSKs being required to increase
expression of ,50% of the RNAs upregulated by ET-1 [9]. As in
other systems, upregulation of cardiomyocyte IEG mRNAs is
acute and transient. For example, activating transcription factor 3
(Atf3) and early growth response 1 (Egr1) mRNAs (each regulated
via ERK1/2) are both upregulated maximally by ET-1 within
,30 min [10]. However, expression of Egr1 mRNA returns to
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basal by ,2 h and expression of Atf3 mRNA declines close to
basal levels over ,4 h. This raises the question of negative
feedback regulation.
Atf3 is emerging as an extremely important feedback regulator
of transcription. Particular emphasis is placed on its role in
inflammation and Atf3 is essential for restraining the immune
response, but Atf3 is also associated with cancer and cardiac
dysfunction [11–14]. However, although it is stress-regulated and
stress-regulating, Atf3 is upregulated in many systems by growth
stimuli including peptide growth factors and GqPCR agonists
[7,15–17]. Atf3 forms homo- or heterodimers that bind to ATF/
CRE sites in gene promoters to regulate transcription [18]. It is
largely regulated at the level of expression, being present at very
low levels in quiescent cells and induced as an IEG by a range of
extracellular stimuli and cellular stresses. ERK1/2 are particularly
implicated in promoting Atf3 mRNA expression and several TFs
may be involved [19–21]. Atf3 is generally viewed as a
transcriptional repressor, particularly when acting as homodimers,
and it may repress transcription from its own promoter to limit
expression [22]. In cardiomyocytes, Atf3 operates in a negative
feedback system with Egr1 and, by binding to the Egr1 promoter,
Atf3 inhibits Egr1 transcription [10]. Mathematical modelling of
the system demonstrated that this, in itself, could suffice for the
transient nature of the Egr1 response. The pivotal role that Atf3
plays in biological systems renders it essential to understand the
mechanisms that regulate Atf3 expression. Here, we have
developed our original mathematical model to determine whether
Atf3 serves as a negative feedback regulator of its own
transcription (as suggested [22]) and to explore other mechanisms
that may switch off Atf3 mRNA expression. We demonstrate that
self-regulation by Atf3 on its own promoter (or, indeed, self-
regulation by any transcription factor) is implausible and miRNAs
are likely to play a dominant role in switching off Atf3 expression
post-induction.
Results
Atf3 mRNA and protein are rapidly and transiently upregulated
in cardiomyocytes exposed to ET-1 (Figure 1A) and, since loss of
Atf3 produces sustained expression of Egr1 mRNA (Figure 1B),
Atf3 negatively regulates Egr1 expression [10]. The initial
deterministic ordinary differential equation model generated for
this Atf3-Egr1 negative feedback system (detailed in [10]) made the
following assumptions: Atf3 and Egr1 are co-regulated through
ERK1/2; ERK1/2 increase transactivating activities of TFs
pre-bound to each promoter (i.e. the TF/promoter constitutes a
single entity regulated by ERK1/2); since ERK1/2 activity
remains high for at least 30 min [23], we did not switch off the
protein kinase signal. This model predicted that Atf3 alone could
suffice to to switch off Egr1 transcription.
To address questions relating to Atf3 transcription we developed
the original model further (Figure 1C). Full details of reaction
equations, mathematical modelling and additional parameterisa-
tion are provided in Text S1. We allowed for the rate of
dephosphorylation (i.e. inactivation) of ERK1/2 following stimu-
lation with ET-1, considering that phosphorylation of ERK1/2 is
maximal at,3 min (Figure 1D, [9]) and declines by,90% by 1 h
with a return to baseline by 2 h [23]. The modelling profile for
ERK1/2 phosphorylation is shown (Figure 1E). We allowed for
the rate of phosphorylation and dephosphorylation of TFs bound
to each of the Atf3 and Egr1 promoters. In other cells,
phosphorylation of CREB and/or c-Jun TFs is implicated in the
upregulation of Atf3 transcription [20,24,25]. In cardiomyocytes
exposed to ET-1, accumulation of phosphorylated (i.e. activated)
CREB and c-Jun TFs each requires ERK1/2 signalling [26,27],
making them prime exemplary candidates for the model.
Experimentally, maximal phosphorylation of CREB is detected
at ,10 min and declines to ,25% maximal by ,60 min
(Figure 1F). The time course for phosphorylated c-Jun is delayed
(maximal at ,45–60 min, declining to ,50% maximal at 2 h
(Figure 1G), because of the additional increase in expression of c-
Jun protein [26]. ET-1 also increases expression of Myc mRNA
(maximal at 1 h) [9] that promotes expression of Atf3 over a longer
time frame in cells treated with serum [19], so the signal could be
perpetuated over a much longer time period. Here, for the Atf3
promoter, the model was initially developed using the profile for
phosphorylated CREB that will give the most rapid rate at which
Atf3 transcription is terminated (Figure 1H). The Egr1 promoter is
most likely regulated by ternary complexes of Elk1/SRF that can
be stimulated either by phosphorylation of Elk1 [28] or an
increase in SRF binding [29]. Elk1 is rapidly and transiently
phosphorylated in cardiomyocytes exposed to phenylephrine with
a similar profile to CREB following exposure to ET-1 [30]. SRF is
upregulated by ET-1 with maximal expression of SRF mRNA at
,1 h [7] and this is likely to perpetuate the response given that
our data indicate that, in the absence of Atf3 expression, Egr1
expression is sustained over at least 2 h (Figure 1B). Thus, for the
TF regulating Egr1 transcription, we used a similar rate of TF
phosphorylation as for CREB with delayed dephosphorylation.
Binding of the TF to the Egr1 promoter was competitive with Atf3
and was modelled in the absence or presence of Atf3 (Figure 1I).
Egr1 mRNA expression remained sensitive to negative feedback
regulation by Atf3 (Figure 1J). With these adjustments, Atf3
mRNA and protein were predicted to decline (Figure 1K), but the
profiles were delayed relative to the experimental data (Figure 1A).
Thus, merely switching off the signal to promote Atf3 transcrip-
tion/translation alone cannot account for its subsequent down-
regulation, indicating that a negative feedback system also operates
for Atf3.
Model extension 1: Atf3 protein inhibits Atf3
transcription
Previous studies used a protein overexpression approach with
reporter assays for the Atf3 promoter to provide evidence that Atf3
operates in an autorepression loop and, by binding to an element
immediately downstream of the TATA box, it inhibits its own
transcription [22]. Since it is difficult to test this experimentally
with an endogenous system, we extended the mathematical model
developed for the Atf3-Egr1 feedback system to determine
Author Summary
Activating transcription factor 3 (Atf3) is an important
regulatory transcription factor which is associated with
inflammation, restraint of the immune response and
cancer. In this work, we develop a series of mathematical
models to understand how Atf3 may be regulated.
Informed with data from the literature and our own
experiments, we show that self-regulation of Atf3 does not
allow for variation between experimentally observed Atf3
mRNA and Atf3 protein expression profiles. A fast-acting
signal via phosphorylated RSK is also shown to be
implausible for similar reasons. Extending our mathemat-
ical model further, we postulate for the first time, that the
observed dynamical variation in Atf3 mRNA and protein
can be described by microRNAs downstream of RSKs. The
further inclusion of an inhibitory transcription factor for
Atf3 expression has little effect on these findings.
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whether a direct Atf3 autorepression loop is feasible (Figure 2A).
The development of this and subsequent mathematical models is
detailed in Text S1. The model extension requires three new
parameters. The association constant for Atf3 protein with Atf3
DNA (K11) was assumed to have an initial value of 0.1 nM. The
forward and reverse rates of the Atf3 protein for Atf3 DNA, l1 and
l21, were also required. l21/l1 was assumed to have a similar
value to K11, but a slow rate of reversal giving a value of
l1 = 1610
5 (Ms)21. With the initial parameters, there was little
effect on Atf3 mRNA, Atf3 protein or Egr1 mRNA profiles
(Figure 2, B–D, solid lines) compared with the original model
(Figure 1K). Decreasing the disassociation constant of Atf3 protein
and Atf3 DNA by 106 produced profiles that were more
representative of the experimental data for Atf3 mRNA and
protein (Figure 2, B and C, dashed lines), but acute inhibition of
Egr1 mRNA expression was lost (Figure 2D, dashed line).
Decreasing the ratio of l21/l1 (informed by a sensitivity analysis)
2 orders of magnitude had no effect on the results. Increasing the
ratio 2 orders of magnitude decreased the amount of Atf3 and
increased the amount of Egr1 as expected (not shown). We
conclude that Atf3 is unlikely to act in an autorepressive manner
on its own promoter. If it did, the rate of accumulation of Atf3
mRNA/protein would be reduced such that it could then not
significantly influence other gene promoters (in this case Egr1)
producing a redundant system. Thus, the Atf3 autorepressive loop
is implausible.
Model extension 2: Simultaneous phosphorylation of an
alternative TF by RSKs inhibits Atf3 transcription
Exposure of cardiomyocytes to BI-D1870, an inhibitor of RSKs
[31], substantially enhances upregulation of Atf3 mRNA by ET-1
(Figure 3A). Although BI-D1870 alone increase ERK1/2 phos-
phorylation in cardiomyocytes, this over a similar time and to a
lesser degree than that induced by ET-1 and it does not affect the
activation of ERK1/2 by ET-1 [9]. It is therefore unlikely that the
enhancement of Atf3 mRNA expression induced by ET-1 seen in
the presence of BI-D1870 is due to its effects on phosphorylation of
ERK1/2 and suggests that a negative feedback system down-
stream of RSKs (or other kinases that may be inhibited by BI-
D1870) moderates Atf3 mRNA expression. Interestingly, the
effects of BI-D1870 over 2 h (Figure 3B) produced a profile for
Atf3 mRNA expression that resembled the predicted profile for
Atf3 mRNA in the modifications to the original model (Figure 1K)
suggesting that an input from RSKs might suffice to switch off Atf3
transcription. We therefore extended the mathematical model to
test the hypothesis that RSKs (as exemplar kinases) phosphorylate
nuclear TFs (RTF) to negatively regulate Atf3 transcription
(Figure 3C). Experimentally, maximal phosphorylation of RSKs
occurs at 5–15 min, declining to ,25% the maximal level by
,30 min (Figure 3D); this profile was modelled mathematically
(Figure 3E, cyan line; see Text S1 for details). The predicted
profile for phospho-RTF binding to the Atf3 promoter is shown in
Figure 3E (red line). Because different signals are applied to
different proteins, we assumed that the negative signal from
phospho-RSK and phospho-RTF was competitive with the
positive signal from phospho-ERK1/2 and phospho-TF. New
parameters were required for the rate of RSK phosphorylation by
phospho-ERK1/2 (k9), the rate of RSK-P dephosphorylation (d10),
rates of association and disassociation of RTF for Atf3 DNA (l2
and l22) and the rates of phosphorylation and dephosphorylation
of RTF bound to Atf3 DNA (k10 and k210). A fit-by-eye to the
RSK data (Figure 3D) yielded k9 = 1610
5 (Ms)21 and
d10=5.9610
24 s21. We assumed that l2 = l1 and l22 = l21,
k10 = k5 and k210 = k25, and that the total amount of RSKs is equal
to the amount of ERK1/2 (i.e. R0 =E0). With the initial
parameters, the profiles for Atf3 mRNA and protein remained
similar to the original model (Figure 1K), although the amount of
each was reduced (Figure 3, F and G) and acute inhibition of Egr1
mRNA remained (Figure 3H). With the competition between
phospho-TF and phospho-RTF for Atf3 DNA, increasing the rate
of association of phospho-RTF with the Atf3 promoter may
produce a profile that approaches that of the experimental data ,
but acute inhibition of Egr1 mRNA expression becomes lost (not
shown). We conclude that the time delay between activation of
ERK1/2 relative to RSKs is too small (1–2 min) to result in
differential effects on mRNA expression over 0.5–4 h if both act
directly on transcription from the same promoter. A greater time
delay may be elicited by termination of transcription by an IEG
encoding an inhibitory TF (ITF) and/or upregulation of a miRNA
(or another factor) promoting Atf3 mRNA degradation and
inhibiting Atf3 protein synthesis.
Model extension 3: Upregulation of an inhibitory TF (ITF)
that inhibits Atf3 transcription
We next tested the hypothesis that downregulation of Atf3
mRNA expression (we retained the assumption that this is via
RSKs) is mediated by upregulation of an ITF (Figure 4A), making
the assumption that the negative effect of ITF was competitive
with the positive signal from ERKs. Five further parameters are
required for this model: the disassociation constant of ITF protein
for Atf3 DNA (K15), the rate of ITF transcription (k13), the rate of
translation of ITF protein (k14), ITF mRNA degradation (d4), and
Figure 1. Experimental data for Atf3 and Egr1 regulation in cardiomyocytes exposed to ET-1 and modifications to the original
mathematical model for the Atf3/Egr1 negative feedback system. A, Experimental data for Atf3 mRNA (solid circles, solid line) and Atf3
protein (open circle, dashed line) levels in cardiomyocytes exposed to 100 nM ET-1 for the times shown. Results are expressed relative to maximum
values as means 6 SEM for at least 3 independent experiments (adapted from data in [10]). B, Experimental data for Egr1 mRNA levels in
cardiomyocytes exposed to 100 nM ET-1 for the times shown in the presence of endogenous Atf3 (open circles, dashed line) or with inhibition of Atf3
(solid circles, solid line). Results are expressed relative to maximum values as means6 SEM for at least 3 independent experiments (adapted from the
data in [10]). C, The original mathematical model [10] was revised (dotted lines) to account for dephosphorylation of ERK1/2 and to include reversible
binding of phosphorylated transcription factors to the Egr1 and Atf3 promoters. Lines with arrows indicate protein activation, DNA transcription or
protein translation. Blocked lines indicate inhibition. Protein and mRNA degradation is indicated by Ø. D, Experimental data for ERK1/2
phosphorylation in cardiomyocytes exposed to ET-1 for the times shown. Data are means for n = 3 independent experiments and are adapted from
the data in [9]. E, Predicted profile from the model for ERK1/2 phosphorylation. F, G, Experimental data for phosphorylation of CREB (F) and c-Jun (G)
in cardiomyocytes exposed to ET-1 for the times shown. Data are means for at least 3 independent experiments and are adapted from data in [26,27].
H, The predicted profile from the model for phosphorylation of the TF bound to the Atf3 promoter was based on experimental data for CREB (F). I,
Predicted profile from the model for phosphorylation of the TF bound to the Egr1 promoter was based on experimental data for CREB for the initial
increase, but the rate of decreased phosphorylation was adjusted such that, in the absence of Atf3, the profile approximated to that of the
experimental data (B). Profiles are shown in the presence (open circle, dashed line) or absence (solid circles, solid line) of Atf3 feedback inhibition. J,
Predicted profiles from the model for Egr1 mRNA expression in the presence (open circle, dashed line) or absence (solid circles, solid line) of Atf3
feedback inhibition. K, Predicted profiles from the model for Atf3 mRNA (solid line) or protein (dashed line) expression.
doi:10.1371/journal.pcbi.1003597.g001
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the rate of ITF protein degradation (d5). On the basis that ITF is
an IEG, we assumed that the disassociation constant of ITF
protein was equal to that of TF for Atf3 DNA (K15 =K10), rates of
transcription and translation of ITF are similar to those for Atf3
(i.e. k13= k6 and k14 = k8), and the rates of degradation of each
mRNA and protein are similar (i.e. d4 = d2 and d5 = d3) producing
the profiles for ITF mRNA and protein shown in Figure 4B. With
initial conditions in which ITF binding to Atf3 DNA is similar to
Figure 2. Model extension 1: Atf3 protein inhibits Atf3 transcription in an autorepressive loop. A, The conceptual model of Atf3 self
regulation in which Atf3 protein suppresses the transcription of Atf3 (dashed line). Symbols are as for Figure 1C. B, C and D, Atf3 mRNA (B, blue lines),
Atf3 protein (C, green lines) and Egr1 mRNA (D, pink lines) concentrations as predicted by the mathematical model using the initial parameter
settings (solid lines) and with a 106-fold increase in the association rate of Atf3 for the Atf3 promoter (long dashed lines). In panels B and C, the
graphs showing a 106-fold increase in the association rate of Atf3 for the Atf3 promoter were also rescaled for comparison with initial parameter
settings (short dashed lines). The predicted curves are superimposed on the experimental data (solid black lines, right axes) to which a spline curve
was fitted.
doi:10.1371/journal.pcbi.1003597.g002
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Atf3 binding to the Egr1 promoter (Figure 4, C and D, solid lines),
there was little change in the profiles compared with the original
model (Figure 1K). Increasing the rate of binding of ITF to Atf3
DNA by 106 produced profiles that were more similar to the
experimental data (Figure 4, C and D, dashed lines), but inhibition
of Egr1 transcription was reduced (Figure 4E, dashed line).
Model extension 4: Upregulation of one or more miRNAs
that regulate Atf3 mRNA and/or protein expression
Transcriptomics studies using Affymetrix exon arrays [9]
identified several miRNAs that are regulated in cardiomyocytes
by ET-1 within 1 h and whose upregulation is inhibited by BI-
D1870 (Table 1; since we have not performed miRNA profiling of
cardiomyocytes, this is unlikely to be a full representation of
miRNAs in this category). Atf3 expression may be regulated by
miRNAs (e.g. Mir663 suppresses Atf3 mRNA expression in
endothelial cells subjected to shear stress [32]). We therefore tested
the hypothesis that upregulation of one or more miRNAs (we
retained the assumption that this is downstream of RSKs as
exemplar kinases) is required to downregulate Atf3 mRNA
expression (Figure 5A). This extension to the model introduces
eight new parameters. With little/no published information on
rates of miRNA turnover, we informed the model as follows. The
rate of phosphorylation/dephosphorylation for RTF binding to
miDNA was assumed to be equal to the rate of phosphorylation/
dephosphorylation of TFs bound to Egr1 and Atf3 DNA by ERK-
P (k16 = k3; k216 = k23). The rate of miDNA transcription was
assumed to be the same as that of Atf3 transcription (k17 = k6) and
the rate at which premiRNA is converted to miRNA (k18) was
assumed to be double the rate of Atf3 translation (0.5/s). The rate
at which miRNA associates with Atf3 mRNA (k19) was assumed to
be equivalent to the rate set for Atf3 protein binding to Egr1 DNA
(16105 (Ms)21) and the reverse rate (k219) was set at 5610
25/s,
the value that gave the best qualitative fit to the experimental data.
The rates of decay of premiRNA (d6) and miRNA (d7) were
assumed to be ,24 h in line with recently published data [33,34].
The rate of decay of the complex miRNA?mRNAAtf3 (d8) was
initially assumed to be the same as that of Atf3 mRNA (d8 = d3).
Mathematical modelling for the production of miRNA is shown in
Figure 5B.
miRNAs may increase mRNA degradation (within a complex
with Ago2) or silence mRNA expression (within Ago1, Ago3 or
Ago4). Computational modelling has been used to predict/
confirm that the increase in mRNA degradation induced by
miRNAs lies within the range 1.3- to 6.4-fold [35]. We first
assumed that potential miRNA(s) had a negligible effect on the
rate of degradation (i.e. the rate of degradation of the miRNA/
mRNA complex was similar to the free mRNA). In this case, the
total Atf3 mRNA (i.e. free Atf3 mRNA + miRNA/mRNA
complex) dynamical profile did not match the experimental data
(Figure 5C, solid line). However, since the miRNA/mRNA
complex is assumed to be translationally incompetent, the protein
profile was significantly affected and approximated to the
experimental profile (Figure 5D, solid line). If we assumed that
potential miRNA(s) increased the rate of degradation of Atf3
mRNA from the miRNA/mRNA complex 2-fold, the total Atf3
mRNA profile approached that of the experimental data
(Figure 5C, long dashed line). Increasing the rate of degradation
4-fold gave a profile that approximated to the experimental data
(Figure 5C, short dashed line). The protein profile was relatively
unaffected by increasing the rate of degradation of the miRNA/
mRNA complex (Figure 5D), indicating that miRNAs have a
dominant effect on protein expression irrespective of their effect on
mRNA expression. In all cases, the predicted Egr1 mRNA profile
approximated to the experimental data over the 2 h period studied
(Figure 5E), although subsequently Egr1 mRNA levels were
predicted to increase as Atf3 protein is lost.
Combining model extensions 3 and 4: Upregulation of
both an ITF and miRNA(s) is required for inhibition of
Atf3 mRNA and protein
We combined the two systems for ITF and miRNA inhibition of
Atf3 to investigate whether an ITF may influence the profiles in
the presence of miRNA(s) (Figure 6A). Profiles for total Atf3
mRNA (Figure 6B), Atf3 protein (Figure 6C) and Egr1 mRNA
(Figure 6D) were similar to those for model extension 4 (Figure 5,
C–E) indicating that miRNAs alone could suffice to switch off Atf3
mRNA and protein expression.
Discussion
In considering mechanisms of regulation of IEG expression, the
emphasis is usually on the signals and transcriptional regulators
required for upregulation. Here, we explored possible mechanisms
associated with downregulation of IEG expression and termination
of the response. We focused on Atf3 as an IEG in which there is
great interest because of its association with inflammation, cancer
and cardiac dysfunction [11–14].
The report that Atf3 can bind to its own promoter to inhibit
transcription [22] is, at first sight, attractive. The experimental
approaches used remain the most appropriate, but all such studies
are potentially subject to artefacts resulting from overexpression or
elimination of a single transcription factor in isolation. Developing
a mathematical model provides an alternative means of testing the
hypothesis. In this case, the model demonstrated that such a
negative feedback loop is implausible in the context of our
cardiomyocyte system (Figure 2). This raises the question of
whether any such self-regulating transcriptional system can
operate. For an inhibitory TF, the model prediction is that a
redundant feedback loop is most likely to be generated in which
the TF serves to regulate only its own expression, restricting the
possibility that it accumulates to a sufficient degree to operate in
an efficient inhibitory loop with another gene. The scenario would
differ in the case of a positive TF driving expression of second
phase genes. Here, self-regulation can provide a means of
moderating downstream gene expression.
Figure 3. Model extension 2: Simultaneous phosphorylation of an alternative transcription factor by RSKs inhibits Atf3
transcription. A and B, Experimental data for the effects of inhibiting MKK1/2 with PD184352 (2 mM) or inhibiting RSKs with BI-D1870 (10 mM) on
Atf3 mRNA expression in unstimulated cells or in cardiomyocytes exposed to ET-1 (100 nM, 1 h; A) or for the times shown (B). Results are expressed
relative to controls as means 6 SEM for n = 3 (A) or 4 (B) independent myocyte preparations. C, The conceptual model was developed to include
phosphorylation of RSKs (RSKP) that phosphorylate a RSK-sensitive TF (RTF) to produce phosphorylated RTF (RTFP) that binds competitively to the
Atf3 promoter to suppress Atf3 transcription. Symbols are as for Figure 1C. D, Experimental data for RSK phosphorylation in cardiomyocytes exposed
to ET-1 for the times shown. Results are means for n = 3 independent experiments and are adapted from the data in [9]. E, Predicted profiles from the
model for RSK phosphorylation (cyan) and RTFP binding to the Atf3 promoter. F, G and H, Atf3 mRNA (F, blue line), Atf3 protein (G, green line) and
Egr1 mRNA (H, pink line) concentrations as predicted by the mathematical model using the initial parameter settings The predicted curves are
superimposed on the experimental data (solid black lines, right axes) to which a spline curve was fitted.
doi:10.1371/journal.pcbi.1003597.g003
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Our experimental data suggest that, whereas ERK1/2 them-
selves promote upregulation of Atf3, downstream activation
of RSKs (or other BI-D1870-sensitive kinases) is potentially
important in terminating Atf3 mRNA and, presumably, protein
expression (Figure 3, A and B). This resulted in the development of
three further extensions to the model. Whilst we have included
Figure 4. Model extension 3: Upregulation of an ITF that inhibits Atf3 transcription. (A) The conceptual model of the ITF inhibitory
pathway for Atf3 transcriptional regulation (dashed lines). Symbols are as for Figure 1C. B, ITF mRNA (left axis, solid line) and ITF protein (right axis,
dashed line) concentrations as predicted by the mathematical model. C, D and E, Atf3 mRNA (C, blue lines), Atf3 protein (D, green lines) and Egr1
mRNA (E, pink lines) concentrations as predicted by the mathematical model using the initial parameter settings (solid lines) and with a 106-fold
increase in the association rate of ITF for the Atf3 promoter (long dashed lines). In panels C and D, the graphs showing a 106-fold increase in the
association rate of ITF for the Atf3 promoter were also rescaled for comparison with initial parameter settings (short dashed lines). The predicted
curves are superimposed on the experimental data (solid black lines, right axes) to which a spline curve was fitted.
doi:10.1371/journal.pcbi.1003597.g004
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biologically appropriate mechanisms at each model revision one
outcome of this has been an increase in the signalling cascade
complexity. This in itself has led to a more robust signalling
response.
The initial concept, that delayed activation of RSKs may result
in delayed activation of a pre-existing inhibitory TF for signal
termination, appeared attractive. However, model extension 2
demonstrated that direct activation of the putative RSK-respon-
sive RTF was almost simultaneous with activation of the ERK1/2-
responsive TF and simply titrated down the levels of Atf3 mRNA
rather than altering the profile. Thus, the delay between activation
of ERK1/2 and activation of RSKs is insufficient for this scenario
to be viable and a greater delay is required before initiation of the
negative signal. Interestingly, since a delay is necessary, this also
negates the possibility of other acute events (e.g. histone
deacetylation) being responsible for terminating Atf3 mRNA
expression. The timing strongly suggests that a second transcrip-
tional event is required, either to produce an alternative inhibitory
TF (termed ITF, model extension 3) and/or one or more miRNAs
(model extension 4). Here, developing first model extensions 3 and
4 independently and then combining the two strongly suggested
that an ITF would not affect Atf3 mRNA and protein expression
whereas miRNA(s) most probably would suffice to generate the
profiles seen experimentally. Interestingly, the miRNA effect was
particularly dominant on the Atf3 protein profile. The model also
demonstrated that a modest increase in the rate of degradation of
Atf3 mRNA by the miRNA within the range predicted by other
computational models [35,36] could suffice for the Atf3 mRNA
profiles to approximate to the experimental data. Further studies
of cardiomyocyte miRNAs are clearly required.
Materials and Methods
Quantitative PCR and microarray data
Neonatal rat cardiomyocytes were prepared as previously
described [37] and exposed to 2 mM PD184352 (to inhibit the
ERK1/2 cascade [38]) or 10 mM BI-D1870 (to inhibit RSKs [31])
for 70 min, to 100 nM ET-1 for 1 h or to inhibitor for 10 min
prior to addition of ET-1 (1 h). PD184352 and BI-D1870 were
from Enzo Life Sciences and were dissolved in DMSO. ET-1 was
from Bachem UK. RNA was extracted and quantitative PCR
performed as described in [10]. Affymetrix microarray data for
cardiomyocytes exposed to ET-1 in the absence or presence of
PD184352 or BI-D1870 were published in [9]. The data are
available from ArrayExpress (accession nos. E-MIMR-3, E-
MIMR-37, E-MEXP-3393, E-MEXP-3394, E-MEXP-3678, E-
MEXP-3679). Probeset sequences that were significantly upregu-
lated and not assigned to a protein-coding gene were analysed by
BLAST search against the rat and mouse genomes (www.ncbi.
nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid = 10116;
www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid
=10090; cross-species megaBLAST) to identify those which
recognise miRNAs.
Data analysis and curve-fitting to experimental data used
GraphPad Prism.
Mathematical modelling
Full details of the mathematical modelling are provided in Text
S1.
Sensitivity analysis. A thorough local sensitivity analysis of
each of the mathematical models was undertaken in which each
parameter value was varied 10- and 100-fold above and below its
originally determined value in fitting to the experimental data
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Figure 5. Model extension 4: Upregulation of one or more miRNAs inhibits Atf3 mRNA and/or protein. A, The conceptual model of the
miRNA inhibitory pathway for Atf3 transcriptional regulation. Symbols are as for Figure 1C. B, The predicted dynamical variation in miRNA
concentration. C, D and E, Predicted concentrations of total Atf3 mRNA (i.e. mRNA + miRNA.mRNA complex) (C, blue lines), Atf3 protein (D, green
lines) and Egr1 mRNA (E, pink lines) when the rate of degradation of Atf3 mRNA within the miRNA.mRNA complex is the same as for degradation of
free Atf3 mRNA (solid lines), is increased 2-fold (long dashed lines) or is increased 4-fold (short dashed lines). The predicted curves are superimposed
on the experimental data (solid black lines, right axes) to which a spline curve was fitted.
doi:10.1371/journal.pcbi.1003597.g005
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Figure 6. Combined model extensions 3 and 4: Upregulation of both an ITF and miRNA(s) is required for inhibition of Atf3 mRNA
and protein. (A) The conceptual model of the ITF and miRNA inhibitory pathways for Atf3 transcriptional regulation (dashed lines). Symbols are as
for Figure 1C. B, C and D, Predicted concentrations of total Atf3 mRNA (i.e. mRNA +miRNA.mRNA complex) (B, blue lines), Atf3 protein (C, green lines)
and Egr1 mRNA (D, pink lines) when the rate of degradation of Atf3 mRNA within the miRNA.mRNA complex is the same as for degradation of free
Atf3 mRNA (solid line), is increased 2-fold (long dashed lines) or is increased 4-fold (short dashed line). The predicted curves are superimposed on the
experimental data (solid black lines, right axes) to which a spline curve was fitted.
doi:10.1371/journal.pcbi.1003597.g006
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CREB, phosphorylated c-Jun, Atf3 mRNA, Atf3 and Egr1
mRNA). Varying the parameter values associated with the
extension of our original mathematical model whereby phosphor-
ylation of transcription factors for Atf3 and Egr1 were explicitly
included, did not give any unexpected results, for instance
variation in the rate of MKK1/2 or ERK phosphorylation did
not affect the fit to the data. The fit to Egr1 mRNA data was found
to be most sensitive to those parameters which decrease the
amount of available Atf3 (decreasing Atf3 transcription, decreasing
Atf3 translation, increasing Atf3 mRNA and Atf3 degradation)
and the rate at which Atf3 supresses Egr1 mRNA.
A sensitivity analysis of the two models in which either Atf3
protein or RSKs inhibit Atf3 transcription showed that no increase
or decrease in parameters associated with each model improved
the fits shown in Figures 2 and 3, respectively. The fit of each
model was particularly sensitive to how much Atf3 was produced
(for instance increasing the rate of RTF association for Atf3 DNA
10-fold simply decreases the amount of Atf3 such that the amount
of Egr1 mRNA increases, removing the transiently observed
decrease around 2 h).
We found that the fits between the remaining three models (ITF
inhibition of Atf3, miRNA regulation of Atf3 mRNA and a
combination of the two) and the experimental data were
particularly robust to variations in parameters associated with
them. For instance increasing the rate of phosphorylation or
reverse phosphorylation of the ITF bound transcription factor
100-fold or any of the degradation rates associated with ITF
mRNA or protein did not alter the transiently observed behaviour
of the model solutions; any increase or decrease in ITF simply
affected the Atf3 concentration. Similar results were found for the
miRNA model extension and the combined extension of ITF and
miRNA upregulation.
Supporting Information
Text S1 Details of the mathematical models including their
derivation, parameterisation, sensitivity analysis and further
solution details.
(PDF)
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